Search results
Biden mostly right on possible outcome of Obamacare repeal
Politifact· 4 days agoPresident Joe Biden’s reelection campaign wants voters to contrast his record on health care policy...
Feds to scrutinize Missouri’s worst-in-the-nation Medicaid application delays - St. Louis Business...
The Business Journals· 14 hours agoBecause of these concerns, the agency will intervene to help Missouri identify strategies to come...
Feds to scrutinize Missouri’s worst-in-the-nation Medicaid application delays
Missouri Independent via Yahoo News· 23 hours agoMissouri’s delays in processing Medicaid applications — among the worst in the nation — have the...
Harrison: Will Gov. Tate Reeves have to flip position on Medicaid expansion to keep pace with Trump?
McComb Enterprise-Journal· 5 hours agoPresident Donald Trump embraces Lt. Gov. Tate Reeves during a campaign rally at BancorpSouth Arena in Tupelo, Miss., Friday, November 1, 2019. As Reeves has argued against Mississippi expanding ...
5 takeaways from the AHIP 2024 conference
Modern Healthcare· 5 days agoAHIP President and CEO Mike Tuffin made a plea for enhanced federal support for Medicare Advantage, which emerged as a trouble spot for health insurance ...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 6 days agoStarting Aug. 1, Blue...begin phasing out coverage of such weight loss drugs as Wegovy, Zepbound and...
Tempus AI IPO raises $410M, at top of the range
Modern Healthcare· 4 days agoAt its $6.2 billion valuation, Tempus’ IPO marks the largest local venture-backed IPO since 2020, when health insurance marketplace GoHealth ...
Feds to scrutinize Missouri’s worst-in-the-nation Medicaid application delays
St. Louis Post-Dispatch· 17 hours agoBecause of these concerns, the agency will intervene to help Missouri identify strategies to come...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 5 days agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy ...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 6 days agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...